Navigation Links
KV Pharmaceutical Company, Purdue Pharma L.P. Settle OxyContin(R) Dispute
Date:6/9/2009

in this press release may contain various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based on or include assumptions concerning the operations, future results and prospects of KV Pharmaceutical company (the "Company"). Such statements may be identified by the use of words like "plan," "expect," "aim," "believe," "project," "anticipate," "commit," "intend," "estimate," "will," "should," "could" and other expressions that indicate future events and trends.

All statements that address expectations or projections about the future, including without limitation, product development, product launches, regulatory approvals, market position, acquisitions, revenues, expenditures, resumption of manufacturing and distribution of products and the impact of the recall and suspension of shipments on revenues, and other financial results, are forward-looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions, the Company provides the following cautionary statements identifying important economic, political and technological factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) changes in the current and future business environment, including interest rates and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized; (3) acceptance and demand for new pharmaceutical products; (4) the introduction and impact of competitive products and pricing, including as a result of so-called authorized-generic drugs; (5) new product development and laun
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia
2. Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
3. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
4. Par Pharmaceutical Begins Shipment of Generic Miacalcin(R)
5. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
6. Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project
7. Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference
8. Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
10. Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications
11. Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Lawrenceville, Georgia (PRWEB) , ... September 03, 2015 ... ... the spread of disease in Haiti, has partnered with Slingshot® Product Development Group ... no electricity or running water. Michael Wahl with DriButts plans to bring 600 ...
(Date:9/3/2015)... ... ... Real Time Pain Relief (RTPR), makers of the popular rub-on pain ... an official endorsement deal with the company. Originally from New South Wales, Australia, Mason ... 15. He is an Australian bull riding champion, following in his uncles’ footsteps in ...
(Date:9/3/2015)... Tamarac, FL (PRWEB) , ... September 03, 2015 ... ... of the Florida Companies to Watch for 2015 by economic development ... one of only 50 companies in the state selected for this prestigious award, ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... estate investment landscape by connecting accredited and institutional investors to real estate investment ... products designed to meet demand from both investors and sponsoring real estate companies. ...
(Date:9/3/2015)... ... ... Girl’s Night Out to benefit Core Compassion Project will be held on ... Monroe, North Carolina. The event food will be provided by Kate Clyde's ... off-premise catering and event services from casual to elegant. They are also the home ...
Breaking Medicine News(10 mins):Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2
... stray cancer cells lurking elsewhere in the body that otherwise ... study in the June 13 issue of the journal ... most may have such indolent cancer cells given the sheer ... them impossible to detect, the researchers said. , The ...
... his famous poem, "Do not go gentle into that good ... dying of the light." Researchers are now backing up this ... to one,s health is critical to good health and survival ... the notion that one should become actively involved in one,s ...
... Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that it ... its Trofex molecular imaging program for the detection ... is designed to investigate two small molecule radiopharmaceutical ... and MIP-1095, in order to select a lead ...
... Foundation, a,nonprofit organization that funds research in early ... five recipients of its Canary,Foundation and American Cancer ... during Canary Foundation,s Early,Detection Symposium in May, the ... of fellows sponsored since the program,s inception in,2004. ...
... supports Courage Center Camps, MINNEAPOLIS, June 12 The ... 2008, at the St. Cloud Country Club. Golfers,will enjoy a ... a,great cause -- Courage Center,s Camp Courage., Registration and ... 1 p.m.,Cost per golfer is $150 or $600 for a ...
... and Life Sciences Customers the DICOM ... EMC Select, ST. PAUL, Minn., June 12 ... grid software for,intelligent medical image management, DICOM and storage ... announced that its DICOM,Services Grid is now available through ...
Cached Medicine News:Health News:Primary tumors can drive the growth of distant cancers 2Health News:Primary tumors can drive the growth of distant cancers 3Health News:Study pinpoints strategies that protect older adult's physical health 2Health News:Molecular insight begins Trofex Ph. 1 trial for detection of metastatic prostate cancer 2Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 2Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 3Health News:Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection 4Health News:DICOM Services Grid(TM) From Acuo Technologies(R) Available Through EMC Select 2
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/lnn7ss/investigation ) has ... on China,s Levothyroxine Market, 2010-2019" report to ... have the greatest effect of promoting growth on ... mainly promote the growth and development of bones, ... (GH) of pipuitary gland can,t work. Besides, pipuitary ...
(Date:9/3/2015)... Sep. 03, 2015 Research ... of the "Investigation Report on China,s Bromhexine Market, ... air pollution worsens, the incidence of respiratory disease keeps ... drugs. Bromhexine, a semisynthetic derivative of vasicine, is a ... and asthma associated with viscid or excessive mucus. It ...
(Date:9/3/2015)... , September 3, 2015 ... subsidiary Lupin Pharmaceuticals, Inc. (Lupin) has launched its ... the first and only generic Duloxetine formulation to ... is excited to bring this new strength to ... dosing options for greater flexibility of treatment. ...
Breaking Medicine Technology:Investigation Report on China's Levothyroxine Market, 2010-2019 2China Bromhexine Market Report 2015-2019 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 3Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: